市場調查報告書

青光眼治療藥報告 (2019年):全球市場分析 2018年∼2024年

2019 Glaucoma Pharmaceuticals Market Report: A Global Analysis for 2018 to 2024

出版商 Market Scope, LLC 商品編碼 644810
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
青光眼治療藥報告 (2019年):全球市場分析 2018年∼2024年 2019 Glaucoma Pharmaceuticals Market Report: A Global Analysis for 2018 to 2024
出版日期: 2019年06月11日內容資訊: 英文
簡介

全球青光眼治療藥市場,至2024年的年複合成長率預計為5.1%。

本報告提供全球青光眼治療藥市場展望,預測急速成長的市場與停滯不前可能性高的市場,輔助眼科醫生的驗光師的作用增加,對開發中國家的青光眼的新興趣的高漲,提高診斷率的最新的診斷技術等相關分析。

調查對象地區(國)

  • 美國
  • 西歐
  • 日本
  • 其他已開發國家
  • 中國
  • 印度
  • 南美
  • 其他的地區

調查專題

  • 青光眼種類與風險要素
  • 疾病的診斷和治療
  • 含眼科醫生和檢眼醫生的全球青光眼醫療提供者狀況
  • 全球患者數的目前的估計與今後五年的預測
  • 現在所販售的青光眼治療藥與其作用機制
  • 學名藥與品牌醫藥品相關的討論和對市場的影響
  • 開發青光眼治療藥的開發平台
  • 製造青光眼治療藥,銷售的企業概要

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

What's New

In the 2019 Glaucoma Pharmaceuticals Market Report, now in its sixth edition, Market Scope forecasts that revenues in the global glaucoma pharmaceuticals market will grow with a CAGR of 5.1 percent to 2024. In the report, we examine growth in the fastest and slowest markets, the growing role of optometrists as ophthalmologist-extenders, new attention to glaucoma in developing countries, and new diagnostic technologies, which will increase the diagnostic rate.

Description

The 2019 Glaucoma Pharmaceuticals Report is Market Scope's comprehensive analysis of the glaucoma pharmaceutical segment of ophthalmology. Our report is designed for members of the ophthalmic industry who participate in this market or are weighing doing so, market analysts, ophthalmologists who treat glaucoma patients, investors, and any other parties who may be interested in the global marketplace of glaucoma pharmaceuticals.

The 2019 Glaucoma Pharmaceuticals Market Report provides provides analysis of current markets for glaucoma medications and forecasts market performance over the next five years. We analyze the global market based on Market Scope's eight regional/economic categories, and we also use these categories in our global forecasts for disease prevalence. The report explores data and information on the disease process, glaucoma populations, glaucoma care, and a range of additional topics intended to provide depth and context to the reader's understanding of this ophthalmic segment. Our coverage includes:

  • Types of glaucoma and risk factors.
  • Diagnosis and treatment of the disease.
  • A global view of glaucoma care providers, including ophthalmologists and optometrists.
  • Current estimates and five-year forecasts for disease prevalence worldwide.
  • Glaucoma medications in the marketplace and their mechanisms of action.
  • Discussion of generic versus branded drugs and their market impact.
  • The development pipeline for glaucoma pharmaceuticals.
  • Profiles of companies making and marketing glaucoma medications.

image1

Author Profile

Peter Downs

image1

Peter Downs has more than 30 years of experience as a business and medical journalist and investigative reporter. He has written for a variety of medical industry publications, including the Medical Business Journal, CBS HealthWatch, and Oncology News International.


Prior to joining Market Scope in 2015 and turning his attention to ophthalmology, Peter analyzed markets for organ and tissue transplantation. Since joining Market Scope, he has traveled to several markets outside the US, including China, Europe, and India, to study ophthalmology at the local level.

In addition to his research and writing efforts on the ophthalmic market, he is also a contributor to Ophthalmic Market Perspectives,

Our report provides analysis of current markets for glaucoma medications and forecasts market performance over the next five years. We analyze the global market based on Market Scope's eight regional/economic categories (US, Western Europe, Japan, Other Wealthy Nations, China, India, Latin America, and Rest of World), and we also use these categories in our global forecasts for disease prevalence. In addition, we explore data and information on the disease process, glaucoma populations, glaucoma care, and a range of additional topics intended to provide depth and context to the reader's understanding of this ophthalmic segment. Our coverage includes:

  • Types of glaucoma and risk factors;
  • Diagnosis and treatment of the disease;
  • A global view of glaucoma care providers, including ophthalmologists and optometrists;
  • Current estimates and five-year forecasts for disease prevalence worldwide;
  • Glaucoma medications in the marketplace and their mechanisms of action;
  • Discussion of generic versus branded drugs and their market impact;
  • The development pipeline for glaucoma pharmaceuticals;
  • Profiles of companies making and marketing glaucoma medications.
Back to Top